Vaishali Pharma Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Hemanth Pathak
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 4.5yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 4.5yrs |
| Promedio de permanencia en la Junta Directiva | 5.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Investors Give Vaishali Pharma Limited (NSE:VAISHALI) Shares A 33% Hiding
Nov 15
A Piece Of The Puzzle Missing From Vaishali Pharma Limited's (NSE:VAISHALI) 27% Share Price Climb
Sep 13The Market Lifts Vaishali Pharma Limited (NSE:VAISHALI) Shares 26% But It Can Do More
Jul 05Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors
Jan 17Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story
Dec 18Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Oct 04With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case
Feb 04Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Aug 20Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?
May 19These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Aug 17A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
May 17Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 17Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Feb 15Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19
Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?
Nov 23CEO
Hemanth Pathak (63 yo)
4.5yrs
Permanencia
Mr. Hemanth Damodar Pathak serves as Chief Executive Officer of Vaishali Pharma Limited from May 26, 2020. He has good experience in the field International Business Development as exposure to more than 90...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 16.6yrs | ₹6.43m | 18.73% ₹ 375.4m | |
| Chief Executive Officer | 4.5yrs | sin datos | sin datos | |
| Chief Financial Officer | 7.5yrs | ₹901.00k | sin datos | |
| Company Secretary & Compliance Officer | 2.9yrs | ₹504.00k | sin datos | |
| Whole Time Director | 15yrs | ₹1.61m | 5.62% ₹ 112.7m | |
| Executive Director | 3.3yrs | ₹1.16m | 0.000010% ₹ 200.4 | |
| Chief Operating Officer | no data | sin datos | 0.000010% ₹ 200.4 |
4.5yrs
Permanencia media
43yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de VAISHALI se considera experimentado (4.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 16.6yrs | ₹6.43m | 18.73% ₹ 375.4m | |
| Whole Time Director | 16.6yrs | ₹1.61m | 5.62% ₹ 112.7m | |
| Executive Director | 6.6yrs | ₹1.16m | 0.000010% ₹ 200.4 | |
| Non Executive & Independent Director | 4.9yrs | ₹6.60k | sin datos | |
| Non-Executive & Independent Director | 4.9yrs | ₹6.60k | sin datos | |
| Non-Executive & Independent Director | 3.3yrs | ₹6.60k | sin datos |
5.8yrs
Permanencia media
56.5yo
Promedio de edad
Junta con experiencia: La junta directiva de VAISHALI se considera experimentada (5.8 años de antigüedad promedio).